New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alnylam Pharmaceuticals, Inc.
ALNY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

35B

Biotechnology

Next Earning date - 13 Feb 2025

35B

Biotechnology

Next Earning date - 13 Feb 2025

276.19USD

Shape-2.06 ( -0.74%)
Market Closed (as of Feb 07, 23:55 EDT)
favorite-chart

Relative Strenght

84
favorite-chart

Volume Buzz

-35%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

9%

Quote Panel

Shape
Updated February 11, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

ALNY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-1.68
vs -2.16

Q1.23

arrow
arrow

N/A

-1.40
vs -2.00

Q2.23

arrow
arrow

N/A

-2.21
vs -2.29

Q3.23

arrow
arrow

+135%

1.15
vs -3.32

Q4.23

arrow
arrow

N/A

-1.10
vs -1.68

Q1.24

arrow
arrow

N/A

-0.16
vs -1.40

Q2.24

arrow
arrow

+125%

0.56
vs -2.21

Q3.24

arrow
arrow

N/A

-0.50
vs 1.15

Q4.24

arrow
arrow

N/A

-0.54
vs -1.10

Q1.25

arrow
arrow

N/A

-0.78
vs -0.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+30%

335M  vs 258.5M

Q1.23

arrow
arrow

+50%

319.3M  vs 213.3M

Q2.23

arrow
arrow

+42%

318.8M  vs 224.8M

Q3.23

arrow
arrow

+184%

750.5M  vs 264.3M

Q4.23

arrow
arrow

+31%

439.7M  vs 335M

Q1.24

arrow
arrow

+55%

494.3M  vs 319.3M

Q2.24

arrow
arrow

+107%

659.8M  vs 318.8M

Q3.24

arrow
arrow

-33%

500.9M  vs 750.5M

Q4.24

arrow
arrow

+32%

582.6M  vs 439.7M

Q1.25

arrow
arrow

+12%

554.3M  vs 494.3M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+131%

1.31
vs 6

Q1.23

arrow
arrow

+67%

0.67
vs 1.31

Q2.23

arrow
arrow

+68%

0.68
vs 0.67

Q3.23

arrow
arrow

-89%

-0.89
vs 0.68

Q4.23

arrow
arrow

+62%

0.62
vs -0.89

Q1.24

arrow
arrow

+30%

0.3
vs 0.62

Q2.24

arrow
arrow

+551%

5.51
vs 0.3

Q3.24

arrow
arrow

-345%

-3.45
vs 5.51

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

517

517
vs 518

0%

Q1.23

arrow
arrow

500

500
vs 517

-3%

Q2.23

arrow
arrow

494

494
vs 500

-1%

Q3.23

arrow
arrow

496

496
vs 494

0%

Q4.23

arrow
arrow

536

536
vs 496

8%

Q1.24

arrow
arrow

554

554
vs 536

3%

Q2.24

arrow
arrow

577

577
vs 554

4%

Q3.24

arrow
arrow

604

604
vs 577

5%

Earnings Growth

Latest News